Cancer Letters, Journal Year: 2025, Volume and Issue: unknown, P. 217772 - 217772
Published: May 1, 2025
Language: Английский
Cancer Letters, Journal Year: 2025, Volume and Issue: unknown, P. 217772 - 217772
Published: May 1, 2025
Language: Английский
Heliyon, Journal Year: 2025, Volume and Issue: unknown, P. e42881 - e42881
Published: Feb. 1, 2025
Language: Английский
Citations
0Current Research in Pharmacology and Drug Discovery, Journal Year: 2025, Volume and Issue: unknown, P. 100217 - 100217
Published: March 1, 2025
Language: Английский
Citations
0Biopolymers, Journal Year: 2025, Volume and Issue: 116(3)
Published: March 19, 2025
ABSTRACT Inflammation processes can cause mild to severe damage in the human body and lead a large number of inflammation‐related diseases (IRD) such as cancer, neural, vascular, pulmonary diseases. Limitations anti‐inflammatory drugs (AID) application are reflected high therapeutic doses, toxicity, low bioavailability solubility, side effects, etc. Polymeric nanosystems (PS) have been recognized safe effective technology that is able overcome these limitations by AID encapsulation answer specific demands IRD treatment. PS attracting great attention due their versatility, biocompatibility, fine‐tuned properties, functionality, ability for precise delivery targeted sites body. This article offers an overview three classes polymeric nanosystems: a) dendrimers, b) micelles nanoparticles, c) filomicelles, well preparation, In future, formulations clinical practice will certainly increase.
Language: Английский
Citations
0Small Methods, Journal Year: 2025, Volume and Issue: unknown
Published: March 30, 2025
Osteoarthritis (OA) is the most prevalent degenerative joint disorder, characterized by progressive degradation, pain, and diminished mobility, all of which collectively impair patients' quality life escalate healthcare expenditures. Current treatment options are often inadequate due to limited efficacy, adverse side effects, temporary symptom relief, underscoring urgent need for more effective therapeutic strategies. Recent advancements in nanomaterials nanomedicines offer promising solutions improving drug bioavailability, reducing effects providing targeted benefits. This review critically examines pathogenesis OA, highlights limitations existing treatments, explores latest innovations intelligent design OA therapy, with an emphasis on their engineered properties, mechanisms, translational potential clinical application. By compiling recent findings, this work aims inspire further exploration innovation nanomedicine, ultimately advancing development personalized therapies.
Language: Английский
Citations
0Bioactive Materials, Journal Year: 2025, Volume and Issue: 50, P. 344 - 363
Published: April 18, 2025
Language: Английский
Citations
0Results in Surfaces and Interfaces, Journal Year: 2025, Volume and Issue: unknown, P. 100529 - 100529
Published: April 1, 2025
Language: Английский
Citations
0Cancer Letters, Journal Year: 2025, Volume and Issue: unknown, P. 217772 - 217772
Published: May 1, 2025
Language: Английский
Citations
0